← Back to headlines
AtaiBeckley (ATAI) to Initiate Phase 3 Depression Study Following Positive FDA Meeting
4 Mar, 16:40 — 4 Mar, 16:40
ℹOnly 1 source covers this story
Read at source (1 outlet)
Related Stories
How autism comes about - The Star | Malaysia
49m ago
Modern cancer drugs still unaffordable for most Indians with head and neck cancers: Patient needs ₹60 lakh for 6 months, says study
1h ago
Ambulance worker suspected of killing five patients in Italy
1h ago
Thinning hair or normal shedding? What to look for and what may help
1h ago